RB-Pathway Disruption Is Associated With Improved Response to Neoadjuvant Chemotherapy in Breast Cancer

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-12-0903
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

MRP1 but Not MDR1 Is Associated With Response to Neoadjuvant Chemotherapy in Breast Cancer Patients

Disease Markers
BiochemistryMedicineClinical BiochemistryMolecular BiologyGenetics
2013English

Multiagent Neoadjuvant Chemotherapy and Tumor Response Are Associated With Improved Survival in Pancreatic Cancer

HPB
HepatologyGastroenterology
2019English

Indoleamine-2,3-Dioxygenase and Interleukin-6 Associated With Tumor Response to Neoadjuvant Chemotherapy in Breast Cancer

Oncotarget
Oncology
2017English

Osteopontin and Vasculogenic Mimicry Formation Are Associated With Response to Neoadjuvant Chemotherapy in Advanced Breast Cancer

OncoTargets and Therapy
OncologyPharmacology
2017English

Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer

Journal of Medical – Clinical Research & Reviews
2019English

Neoadjuvant Chemotherapy in Breast Cancer

English

Amplification of 7p12 Is Associated With Pathologic Non-Response to Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer

American Journal of Pathology
Forensic MedicinePathology
2020English

Aldehyde Dehydrogenase 1A1 Expression in Breast Cancer Is Associated With Stage, Triple Negativity, and Outcome to Neoadjuvant Chemotherapy

Modern Pathology
Forensic MedicinePathology
2012English

Neoadjuvant Chemotherapy: Role in Breast Cancer

2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy